Speakers

Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 8th Neuroimmunology Drug Development Summit.

Markus Kummer

Senior Principal Scientist - Research
AbbVie

Susan Acton

Neuroinflammation Research Head
Adiso Therapeutics

Ralph Minter

Chief Scientific Officer
Alchemab Therapeutics

Julia Kuhn

Associate Director - Target Discovery & Genomics
Alector

Martin Jacko

Founder & Chief Executive Officer
Aperture Therapeutics

Peter Flynn

President & Chief Executive Officer
Arialys Therapeutics

John Silbereis

Principal Scientist & Preclinical Program Leader
Biogen

Kevin Dines

Scientific Executive Director
Bristol Myers Squibb

Andrew Kaplan

Principal Scientist & Lab Head
Bristol Myers Squibb

Horia Pribiag

Scientist, Stanley Center for Psychiatric Research
Broad Institute of MIT & Harvard

Matthew Johnson

Senior Group Leader
Broad Institute of MIT & Harvard

Daniel Wilton

Postdoctoral Research Fellow, Boston Children’s Hospital
Harvard Medical School

Jagadeesh Rao

Principal Scientist
IGC PHARMA

Hella Kohlhof

Chief Scientific Officer
Immunic Therapeutics

Tarek Samad

Senior Vice President & Global Head, Research
Lundbeck

Michael Levy

Research Director, Division of Neuroimmunology & Neuroinfectious Disease
Massachusetts General Hospital

Rebecca Mathew

Principal Scientist
Merck

Christian Mirescu

Chief Scientific Officer
Monument Biosciences

Charles Mobbs

Professor, Neuroscience, Endocrinology, Geriatrics, & Pharmacology & Therapeutics Discovery
Mount Sinai School of Medicine

Niels Plath

Chief Scientific Officer
Muna Therapeutics

Paul Song

Chief Executive Officer
NKGen Biotech

Ioannis-Alexandros Gampierakis

Postdoctoral Research Fellow, Inflammation & Immunology
Pfizer

Dimitry Ofengeim

Head of Precision Neurology & Neuroinflammation Cluster
Sanofi

Agnes Cheong

Senior Scientist
Sanofi

Aaron Kantor

Head of Research
Therini Bio

Borislav Dejanovic

Senior Director, Translational Sciences
Vigil Neuroscience, a Sanofi Company

Explore the Agenda

Discover cutting-edge sessions on neuroinflammatory mechanisms, glial biology, peripheral immune targets, and translational biomarkers redefining CNS drug development.

View Presentations & Speakers

Partner With Us

Connect with senior discovery, preclinical, and translational neuroscientists seeking innovative targets, models, and omics solutions to advance neuroimmunology pipelines.

Explore Sponsorship Options

Join Biopharma Experts

Network with industry pioneers shaping the next generation of immune-modulating therapies for neuroinflammatory and neuroimmune disorders.